(NEW YORK)–Real Brands, Inc. (OTCMKTS: RLBD) saw its price and volume spike on completion of merger with marijuana cigarette and vaporize company CBD Pharmacy.
The Company recently announced they had acquired the CBD Pharmacy trademark™ plus four (4) US utility patents for the manufacture of consumable legal cannabis and hemp products as defined by the states on a state by state basis.
In addition RLBD has also agreed to acquire four (4) Colorado trademarks for use in legal cannabis and hemp products.
The four (4) additional Colorado trademarks are:
Cannabis Smoke Tobacco
Currently, 28 states and Washington, DC have legalized medicinal and/or recreational cannabis use and the industry is already estimated to be a multiple billion dollar industry, making the timing for brand building optimal. As consumers become increasingly aware of the medicinal benefits of Cannabis and CBD’s, the industry is expected to continue growing over 20% annually through 2021.*
“Since signing the binding letter of intent in May of this year we have been focusing on the CBD Pharmacy line and we have finalized the new CBD Pharmacy™ logo and packaging design,” said Jerry Pearring, CEO of Real Brands, Inc. “We anticipate our licensees will introduce the CBD Pharmacy line of Vape Cartridges into several states in the coming months, while we simultaneously develop new products for the CBD Pharmacy line and explore opportunities for all of our trademarks and utility patents.”
The four (4) utilities patents include:
An Inhaler for the consumption of Cannabinoids
Cannabis Infused Chewing Composition
A Method of Manufacturing a Smokable Cannabis Product
Cannabis Smokeless Tobacco
This merger now puts RLBD in the same sector as such other plays as mCig, Inc (OTCMKTS:MCIG) and VAPE Holdings (OTCMKTS:VAPE)
Ludlow Research, a smallcap equity research firm based in New York City, reiterated their coverage on RLBD based on their recent acquisitions, and low market cap valuation, with a short-term valuation target on RLBD of $0.15+ per share.
Real Brands, Inc. is traded on the OTC market under the ticker symbol “RLBD”.
About Real Brands
Real Brands, Inc. (RLBD) is a publicly held company. The Company’s strategy is to build brands and is currently focusing on consumer products brand development and marketing in the legal hemp and cannabis industry. Real Brands, Inc. currently has a super majority controlling equity interest in Omega Hemp Water trademarks and intellectual properties. For additional information go to www.realbrandsusa.com
Register for Updates
To receive updates, or to be added to our investor mailing list, please visit https://wallstreetnewscast.com/investors/
(Please indicate which company you are interested in the subject box provided)
This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Wall Street Newscast (“WSNC”) does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. WSNC, its affiliates, or directors, may or may not hold a position in the above security from time to time, and investors are encourage to consider this as a possible conflict of interest when reviewing this information. In Compliance with SEC Rule 17B Wall Street Newscast was not compensated for ongoing media advisory services, and thus should be considered a possible conflict of interest when reviewing this report and information. WSNC, or its affiliates, may hold a position in above securities from time to time, and thus should be considered a possible conflict of interest when reviewing this report and information. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial advisor before any and all investments.
Safe Harbor Statements:
This website includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
Small and Micro cap, or ‘penny stocks’, involve a high degree of risk, and we highly encourage investors to consult with a financial advisor before making any and all investment decisions when investing in these type of securities.
- FDA Guidance on CBD Infused Products May Signal Bottom for Stock Sector - August 17, 2019
- Vectorspace AI (VXV) and ESTC Discuss Visualizing Alpha Utilizing Datasets and Canvas - August 8, 2019
- Vectorspace (VXV) Crypto Coin Big Uses for Quant Hedge Funds - July 1, 2019
- BioHemp (BKIT) Added to Watch List as CBD Distribution Play - June 28, 2019
- Hammer Fiber (HMMR) Moves Towards Profit in Earnings Report - June 27, 2019
- Maybe It’s Time to Automate Politicians to History Bin Using AI - April 21, 2019
- Biopharma Growth Opportunities in China, Thurs. April 4th in NYC - April 2, 2019
- IPO Schedule This Week: MITO KLDO CSTX PSTX - February 4, 2019
- IPO Investor Watch: ANCN HKIT HOTH - February 2, 2019
- CIIX Reports +43% Revenue Growth, CBD Sales Increase 8x over 2018 - January 23, 2019